4-Demethoxydaunomycin
CAS: 58957-92-9
Rif. 3D-FD137552
5mg | Fuori produzione | ||
10mg | Fuori produzione | ||
25mg | Fuori produzione |
Informazioni sul prodotto
- Idarubicin
4-Demethoxydaunomycin (4DMXD) is a drug that belongs to the class of anthracyclines. It is structurally similar to idarubicin and daunorubicin, but it has a different mechanism of action. 4DMXD inhibits DNA synthesis by binding to nuclear DNA, which may be the result of competitive inhibition with deoxycytidine kinase. This drug has been shown to have cytotoxic effects on mouse tumor cells in vitro and leukemia cells in vivo. It also has anti-inflammatory properties and can inhibit prostaglandin synthesis. 4DMXD is currently being studied for potential use in the treatment of various types of cancer, including myelogenous leukemias, lymphomas, and other cancers such as prostate cancer.